Lambert-Eaton syndrome antibodies target multiple subunits of voltage-gated Ca2+ channels

Muscle and Nerve

Volumn 51, Issue 2, 2015, Pages 176-184

  Hajela, Ravindra K ^a   Huntoon, Kristin M ^a,b   Atchison, William D ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Acetylcholine release; Lambert Eaton myasthenic syndrome; Neuromuscular disease; Small cell lung carcinoma; Voltage gated Ca2+ channels

Indexed keywords

AUTOANTIBODY; CALCIUM CHANNEL; GREEN FLUORESCENT PROTEIN; PROTEIN SUBUNIT;

BLOOD; EATON LAMBERT SYNDROME; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; METABOLISM; PROTEIN SUBUNIT; SMALL CELL CARCINOMA;

AUTOANTIBODIES; CALCIUM CHANNELS; CARCINOMA, SMALL CELL; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; PROTEIN SUBUNITS; TRANSFECTION;

EID: 84920955765     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.24295     Document Type: Article

References (55)

1. Lambert EH, Eaton LM, Rooke ED. Defect of neuromuscular conduction associated with malignant neoplasm. Am J Physiol 1956;187:612-613.
2. Vincent A, Lang B, Newsom-Davis J. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci 1989;12:496-502.
3. Sher E, Carbone E, Clementi F. Neuronal calcium channels as target for Lambert-Eaton myasthenic syndrome autoantibodies. Ann NY Acad Sci 1993;681:373-381.
4. Katz E, Ferro PA, Weiss G, Uchitel OD. Calcium channels involved in synaptic transmission at the mature and regenerating mouse neuromuscular junction. J Physiol (Lond) 1996;497:687-689.
5. + channels in evoked release of norepinephrine from sympathetic neurons. Science 1998;239:57-61.
6. Lemos JR, Nowycky MC. Two types of calcium channels coexist in peptide-releasing vertebrate nerve terminals. Neuron 1989;2:1419-1426.
7. Owen PJ, Marriott DB, Boarder MR. Evidence for a dihydrophyridine-sensitive and conotoxin-insensitive release of noradrenaline and uptake of calcium in adrenal chromaffin cells. Br J Pharmacol 1989;97:133-138.
8. Waterman SA. Role of N-, P-, and Q-type voltage-gated calcium channels in transmitter release from sympathetic neurones in the mouse isolated vas deferens. Br J Pharmacol 1997;120:393-398.
9. Waterman SA. Voltage-gated calcium channels in autonomic neuroeffector transmission. Prog Neurobiol 2000;60:181-210.
10. Waterman SA. Autonomic dysfunction in Lambert-Eaton myasthenic syndrome. Clin Auton Res 2001;11:145-154.
11. Benatar M, Blaes F, Johnston I, Wilson K, Vincent A, Beeason D, et al. Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell line. J Neuroimmunol 2001;113:153-162.
12. Sabater L, Titulaer M, Saiz A, Verschuuren J, Gure AO, Graus, F. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology 2008;70:924-928.
13. Takamori M, Maruta T, Komai K. Lambert-Eaton myasthenic syndrome as an autoimmune calcium channelopathy. Neurosci Res 2000;36:183-191.
14. Cull-Candy SG, Miledi R, Trautmann A, Uchitel OD. On the release of transmitter at normal, myasthenia gravis and myasthenic syndrome affected human end-plates. J Physiol (Lond) 1980;299:621-638.
15. Lambert EH, Elmqvist D. Quantal components of end-plate potentials in the myasthenic syndrome. Ann NY Acad Sci 1971;183:183-199.
16. Lang B, Newsom-Davis J, Prior C, Wray D. Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse. J Physiol (Lond) 1983;344:335-345.
17. Kim YI. Lambert-Eaton myasthenic syndrome: evidence for calcium channel blockade. Ann NY Acad Sci 1987;505:377-379.
18. Kim YI, Neher E. IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels. Science 1998;239:405-408.
19. + flux in a human small cell carcinoma line. Nature 1985;317:737-739.
20. Peers C, Lang B, Newsom-Davis J, Wray DW. Selective action of myasthenic syndrome antibodies on calcium channels in a rodent neuroblastoma × glioma cell line. J Physiol (Lond) 1990;421:293-308.
21. Flink MT, Atchison WD. Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission. J Physiol (Lond) 2002;543:567-576.
22. Smith DO, Conklin MW, Jensen PJ, Atchison WD. Decreased calcium currents in motor nerve terminals of mice with Lambert-Eaton myasthenic syndrome. J Physiol (Lond) 1995;487:115-123.
23. Garcia KD, Beam KG. Reduction of calcium currents by Lambert-Eaton syndrome sera: motoneurons are preferentially affected, and L-type currents are spared. J Neurosci 1996;16:4903-4913.
24. Garcia KD, Mynlieff M, Sanders DB, Beam KG, Walrond JP. Lambert-Eaton sera reduce low-voltage and high-voltage activated Ca2+ currents in murine dorsal root ganglion neurons. Proc Natl Acad Sci USA 1996;93:9264-9269.
25. Pinto A, Gillard S, Moss F, Whyte K, Brust P, Williams M, et al. Human autoantibodies specific for the α1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons. Proc Natl Acad Sci USA 1998;95:8328-8333.
26. Pinto A, Iwasa K, Newland C, Newsom-Davis J, Lang B. The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels. Muscle Nerve 2002;25:715-724.
27. Rosenfeld MR, Wong E, Dalmau J, Manley G, Posner JB, Sher E, et al. Cloning and characterization of a Lambert-Eaton myasthenic syndrome antigen. Ann Neurol 1993;33:113-120.
28. Veschuuren JJ, Dalmau J, Tunkel R, Lang B, Graus F, Schramm L, et al. Antibodies against the calcium channel beta-subunit in Lambert-Eaton myasthentic syndrome. Neurology 1998;50:475-479.
29. Iwasa K, Pinto A, Vincent A, Lang B. LEMS IgG binds to extracellular determinants on N-type voltage-gated calcium channels, but does not reduce VGCC expression. Ann NY Acad Sci 2003;998:196-199.
30. Lang B, Pinto A, Giovannini F, Newsom-Davis J, Vincent A. Pathogenic autoantibodies in the Lambert-Eaton myasthenic syndrome. Ann NY Acad Sci 2003;998:187-195.
31. 1A-containing high-voltage-activated calcium channels. Biophys J 1999;76:1384-1400.
32. Williams ME, Brust PF, Feldman DH, Patthi S, Simerson S, Maroufi A, et al. Structure and functional expression of an omega-conotoxin-sensitive human N-type calcium channel. Science 1992;257:389-395.
33. 1E calcium channel subtypes. J Biol Chem 1994;269:22347-22357.
34. 2, and β subunits of a novel human neuronal calcium channel subtype. Neuron 1992;8:71-84.
35. + channels transiently expressed in human embryonic kidney 293 cells. Mol Pharmacol 2002;62:1418-1430.
36. Wirtz PW, Roep BO, Schreuder GM, van Doorn PA, van Engelen BG, Kuks JB, et al. HLA class I and II in Lambert-Eaton myasthenic syndrome without associated tumor. Human Immunol 2001;62:809-813.
37. Giovannini F, Sher E, Webster R, Boot J, Lang B. Calcium channel subtypes contributing to acetylcholine release from normal, 4-amino-pyridine-treated and myasthenic syndrome auto-antibodies-affected neuromuscular junctions. Br J Pharmacol 2002;136:1135-1145.
38. + channels. J Pharmacol Exp Ther 2006;319:1009-1020.
39. Ca in mouse motor nerve terminals. J Neurophysiol 1998;80:1056-1069.
40. Campbell DB, Hess EJ. L-type calcium channels contribute to the tottering mouse dystonic episodes. Mol Pharmacol 1999;55:23-31.
41. Leveque C, Hoshino T, David P, Shoji-Kasai Y, Leys K, Omori A, et al. The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen. Proc Natl Acad Sci USA 1992;89:3625-3629.
42. Takamori M, Motomura M, Fukudome T, Yoshikawa H. Autoantibodies against M1 muscarinic acetylcholine receptor in myasthenic disorders. Eur J Neurol 2007;14:1230-1235.
43. 1B and β subunits during rat brain ontogeny. J Biol Chem 1998;273:14495-14502.
44. 1B and β subunits in epileptic lethargic (lh) mouse. J Biol Chem 1998;273:21435-21438.
45. + channel subunit compositions in lethargic mouse brain. Mol Cell Neurosci 1999;13:293-311.
46. Burton DR. A vaccine for HIV type 1: the antibody perspective. Proc Natl Acad Sci USA 1997;94:10018-10023.
47. VanCott TC, Betake FR, Burke DS, Redfield RR, Birx DL. Lack of induction of antibodies specific for conserved, discontinuous epitopes of HIV-1 envelope glycoprotein by candidate AIDS vaccines. J Immunol 1995;155:4100-4110.
48. Gao B, Sekido Y, Maximov A, Saad M, Forgacs E, Latif F, et al. Functional properties of a new voltage-dependent calcium channel α2δ auxiliary subunit gene (CACANA2D2). J Biol Chem 200;275:12237-12242.
49. 2δ subunit. J Neurosci 1999;19:684-691.
50. 4 subunit. Mol Pharmacol 2002;62:485-496.
51. Arikanth J, Campbell KP. Auxiliary subunits: essential components of the voltage gated calcium channel complex. Curr Opin Neurobiol 2003;13:298-307.
52. Oh SJ, Sher E. MG and LEMS overlap syndrome: case report with electrophysiological and immunological evidence. Clin Neurophysiol 2005;116:1167-1171.
53. Roohi F, Smith PR, Bergman M, Baig MA, Sclar G. A diagnostic and management dilemma: combined paraneoplastic myasthenia gravis and Lambert-Eaton myasthenic syndrome presenting as acute respiratory failure. Neurologist 2006;12:322-326.
54. Kim JA, Lim YM, Jang EH, Kim KK. A patient with coexisting myasthenia gravis and Lambert-Eaton myasthenic syndrome. J Clin Neurol 2012;8:235-237.
55. Sha SJ, Layzer RB. Myasthenia gravis and Lambert-Eaton myasthenic syndrome in the same patient. Muscle Nerve 2007;36:115-117.